Gold - weekly market update on 4H chart - where to buy
Dear traders and followers,
welcome to our weekly gold market update !
Yesterday the Gold market dumped after Pfizer and Biontech released a success in Vaccine development. The success rate for this vaccine is near 90 % but I expect first sells in the middle of 2021 because the vaccine approval trough gouvernment needs a lot of time. Yesterday was only a short term FOMO day which brought great buy entry for Gold. Don't forget the economy is still very bad. A lots of insolvencys will be published in 2021 especially in Germany because the insolvency reporting has been stopped in 2020 by the gouvernment and starts again in 2021. Gold is still long term bullish until it stay above 1700 $ area
Feel free to leave a comment or to share your ideas in the comments section
Please hit the like button if you share or like this idea.
Follow us and stay up to date/don't miss any new ideas
Thanks for your support !
welcome to our weekly gold market update !
Yesterday the Gold market dumped after Pfizer and Biontech released a success in Vaccine development. The success rate for this vaccine is near 90 % but I expect first sells in the middle of 2021 because the vaccine approval trough gouvernment needs a lot of time. Yesterday was only a short term FOMO day which brought great buy entry for Gold. Don't forget the economy is still very bad. A lots of insolvencys will be published in 2021 especially in Germany because the insolvency reporting has been stopped in 2020 by the gouvernment and starts again in 2021. Gold is still long term bullish until it stay above 1700 $ area
Feel free to leave a comment or to share your ideas in the comments section
Please hit the like button if you share or like this idea.
Follow us and stay up to date/don't miss any new ideas
Thanks for your support !
Comentário:
another possible movement/sell entry in case that Gold break last high at 1885 $
Comentário:
update for Friday the 13th
Trade ativo
Trade fechado manualmente:
closed at break even
The analyses provided are for informational purposes only and do not constitute financial advice or recommendations to buy or sell anything. The information presented is based on personal research and interpretation.
